{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T19:51:18Z","timestamp":1792439478120,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,8,13]],"date-time":"2012-08-13T00:00:00Z","timestamp":1344816000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2012,8,13]],"date-time":"2012-08-13T00:00:00Z","timestamp":1344816000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Cardiogenic shock (CS) remains the leading cause of death in patients hospitalized for myocardial infarction (MI). Systemic inflammation with inappropriate vasodilatation is observed in many patients with CS and may contribute to an excess mortality rate. The purpose of this study was to determine the predictive role of serial measurements of Nt-proBNP, interleukin-6 (IL-6), and procalcitonin (PCT) for 30-day mortality in patients with CS due to MI.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>The present study is a prospective single-center study including 87 patients with MI complicated by CS treated with acute revascularization and intraaortic balloon counterpulsation (IABP) support. Predictive values of plasma levels at admission (T<jats:sub>0<\/jats:sub>), after 24 hours (T<jats:sub>1<\/jats:sub>), and after 72 hours (T<jats:sub>2<\/jats:sub>) were examined according to 30-day mortality.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>Significant differences between survivors (<jats:italic>n<\/jats:italic> = 59) and nonsurvivors (<jats:italic>n<\/jats:italic> = 28) were seen for Nt-proBNP at T<jats:sub>0<\/jats:sub>, for IL-6 at T<jats:sub>0<\/jats:sub> and T<jats:sub>1<\/jats:sub>, and for PCT at T<jats:sub>1<\/jats:sub> and T<jats:sub>2<\/jats:sub>. According to ROC analyses, the highest accuracy predicting 30-day mortality was seen at T<jats:sub>0<\/jats:sub> for IL-6, at T<jats:sub>1<\/jats:sub> for PCT, and at T<jats:sub>2<\/jats:sub> for PCT. In univariate analysis, significant values were found for Nt-proBNP at T<jats:sub>1<\/jats:sub>, and for IL-6 and PCT at all points in time. Within the multivariate analysis, age, creatinine, and IL-6 were significant determinants of 30-day mortality, in which IL-6 showed the highest level of significance.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>In patients with MI complicated by CS, IL-6 represented a reliable independent early prognostic marker of 30-day mortality. PCT revealed a significant value at later points in time, whereas Nt-proBNP seemed to be of lower relevance.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/cc11467","type":"journal-article","created":{"date-parts":[[2012,8,13]],"date-time":"2012-08-13T10:14:18Z","timestamp":1344852858000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Interleukin-6 is the strongest predictor of 30-day mortality in patients with cardiogenic shock due to myocardial infarction"],"prefix":"10.1186","volume":"16","author":[{"given":"Ren\u00e9 P","family":"Andri\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich M","family":"Becher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricarda","family":"Frommold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vedat","family":"Tiyerili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan W","family":"Schrickel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Nickenig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg O","family":"Schwab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,8,13]]},"reference":[{"key":"733_CR1","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1001\/jama.294.4.448","volume":"294","author":"A Babaev","year":"2005","unstructured":"Babaev A, Frederick PD, Pasta DJ, Every N, Sichrovsky T, Hochman JS: Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock; NRMI Investigators. JAMA. 2005, 294: 448-454. 10.1001\/jama.294.4.448.","journal-title":"JAMA"},{"key":"733_CR2","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1161\/CIRCULATIONAHA.108.814947","volume":"119","author":"RJ Goldberg","year":"2009","unstructured":"Goldberg RJ, Spencer FA, Gore JM, Lessard D, Yarzebski J: Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective. Circulation. 2009, 119: 1211-1219. 10.1161\/CIRCULATIONAHA.108.814947.","journal-title":"Circulation"},{"key":"733_CR3","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1001\/jama.285.2.190","volume":"285","author":"JS Hochman","year":"2001","unstructured":"Hochman JS, Sleeper LA, White HD, Dzavik V, Wong SC, Menon V, Webb JG, Steingart R, Picard MH, Menegus MA, Boland J, Sanborn T, Buller CE, Modur S, Forman R, Desvigne-Nickens P, Jacobs AK, Slater JN, LeJemtel TH: SHOCK Investigators: Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock: one-year survival following early revascularization for cardiogenic shock. JAMA. 2001, 285: 190-192. 10.1001\/jama.285.2.190.","journal-title":"JAMA"},{"key":"733_CR4","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1001\/jama.295.21.2511","volume":"295","author":"JS Hochman","year":"2006","unstructured":"Hochman JS, Sleeper LA, Webb JG, Dzavik V, Buller CE, Aylward P, Col J, White HD, for the SHOCK Investigators: Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. JAMA. 2006, 295: 2511-2515. 10.1001\/jama.295.21.2511.","journal-title":"JAMA"},{"key":"733_CR5","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1161\/CIRCULATIONAHA.106.613596","volume":"117","author":"HR Reynolds","year":"2008","unstructured":"Reynolds HR, Hochman JS: Cardiogenic shock: current concepts and improving outcomes. Circulation. 2008, 117: 686-697. 10.1161\/CIRCULATIONAHA.106.613596.","journal-title":"Circulation"},{"key":"733_CR6","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1056\/NEJMoa020233","volume":"347","author":"AS Maisel","year":"2002","unstructured":"Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, Omland T, Storrow AB, Abraham WT, Wu AH, Clopton P, Steg PG, Westheim A, Knudsen CW, Perez A, Kazanegra R, Herrmann HC, McCullough PA, Breathing Not Properly Multinational Study Investigators: Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002, 347: 161-167. 10.1056\/NEJMoa020233.","journal-title":"N Engl J Med"},{"key":"733_CR7","doi-asserted-by":"publisher","first-page":"3206","DOI":"10.1161\/01.CIR.0000147611.92021.2B","volume":"110","author":"C Heeschen","year":"2004","unstructured":"Heeschen C, Hamm CW, Mitrovic V, Lantelme NH, White HD, Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Investigators: N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes. Circulation. 2004, 110: 3206-3212. 10.1161\/01.CIR.0000147611.92021.2B.","journal-title":"Circulation"},{"key":"733_CR8","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1097\/01.CCM.0000229144.97624.90","volume":"34","author":"A Rudiger","year":"2006","unstructured":"Rudiger A, Gasser S, Fischler M, Hornemann T, von Eckardstein A, Maggiorini M: Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure. Crit Care Med. 2006, 34: 2140-2144. 10.1097\/01.CCM.0000229144.97624.90.","journal-title":"Crit Care Med"},{"key":"733_CR9","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1001\/archinte.165.14.1643","volume":"165","author":"S Kohsaka","year":"2005","unstructured":"Kohsaka S, Menon V, Lowe AM, Lange M, Dzavik V, Sleeper LA, Hochman JS: Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock. Arch Intern Med. 2005, 165: 1643-1650. 10.1001\/archinte.165.14.1643.","journal-title":"Arch Intern Med"},{"key":"733_CR10","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1097\/00003246-200209000-00007","volume":"30","author":"A Geppert","year":"2002","unstructured":"Geppert A, Steiner A, Zorn G, Delle-Karth G, Koreny M, Haumer M, Siostrzonek P, Huber K, Heinz G: Multiple organ failure in patients with cardiogenic shock is associated with high plasma levels of interleukin-6. Crit Care Med. 2002, 30: 1987-1994. 10.1097\/00003246-200209000-00007.","journal-title":"Crit Care Med"},{"key":"733_CR11","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1097\/01.CCM.0000228919.33620.D9","volume":"34","author":"A Geppert","year":"2006","unstructured":"Geppert A, Dorninger A, Delle-Karth G, Zorn G, Heinz G, Huber K: Plasma concentrations of interleukin-6, organ failure, vasopressor support, and successful coronary revascularization in predicting 30-day mortality of patients with cardiogenic shock complicating acute myocardial infarction. Crit Care Med. 2006, 34: 2035-2042. 10.1097\/01.CCM.0000228919.33620.D9.","journal-title":"Crit Care Med"},{"key":"733_CR12","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1097\/CCM.0B013E318165BABB","volume":"36","author":"KL Becker","year":"2008","unstructured":"Becker KL, Snider R, Nylen ES: Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Crit Care Med. 2008, 36: 941-952. 10.1097\/CCM.0B013E318165BABB.","journal-title":"Crit Care Med"},{"key":"733_CR13","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.jemermed.2010.05.073","volume":"41","author":"F Bektas","year":"2011","unstructured":"Bektas F, Soyuncu S, Gunduz I, Basarici I, Akbas H, Eken C: The value of procalcitonin, a novel inflammatory marker, in the diagnosis of myocardial infarction and evaluation of acute coronary syndrome patients. J Emerg Med. 2011, 41: 524-530. 10.1016\/j.jemermed.2010.05.073.","journal-title":"J Emerg Med"},{"key":"733_CR14","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1080\/17482940701534800","volume":"10","author":"N Kafkas","year":"2008","unstructured":"Kafkas N, Venetsanou K, Patsilinakos S, Voudris V, Antonatos D, Kelesidis K, Baltopoulos G, Maniatis P, Cokkinos DV: Procalcitonin in acute myocardial infarction. Acute Card Care. 2008, 10: 30-36. 10.1080\/17482940701534800.","journal-title":"Acute Card Care"},{"key":"733_CR15","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1056\/NEJM199908263410901","volume":"341","author":"JS Hochman","year":"1999","unstructured":"Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, Buller CE, Jacobs AK, Slater JN, Col J, McKinlay SM, LeLemtel TH: Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med. 1999, 341: 625-634. 10.1056\/NEJM199908263410901.","journal-title":"N Engl J Med"},{"key":"733_CR16","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jacc.2004.04.033","volume":"44","author":"JL Mega","year":"2004","unstructured":"Mega JL, Morrow DA, De Lemos JA, Sabatine MS, Murphy SA, Rifai N, Gibson CM, Antman EM, Braunwald E: B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy. J Am Coll Cardiol. 2004, 44: 335-339. 10.1016\/j.jacc.2004.04.033.","journal-title":"J Am Coll Cardiol"},{"key":"733_CR17","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.amjcard.2005.11.029","volume":"97","author":"G Ndrepepa","year":"2006","unstructured":"Ndrepepa G, Braun S, Mehilli J, von Beckerath N, Nekolla S, Vogt W, Schwaiger M, Sch\u00f6mig A, Kastrati A: N-terminal pro-brain natriuretic peptide on admission in patients with acute myocardial infarction and correlation with scintigraphic infarct size, efficacy of reperfusion, and prognosis. Am J Cardiol. 2006, 97: 1151-1156. 10.1016\/j.amjcard.2005.11.029.","journal-title":"Am J Cardiol"},{"key":"733_CR18","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1093\/eurheartj\/ehi260","volume":"26","author":"B Verg\u00e8s","year":"2005","unstructured":"Verg\u00e8s B, Zeller M, Desgr\u00e8s J, Dentan G, Laurent Y, Janin-Manificat L, L'Huillier I, Rioufol G, Beer JC, Makki H, Rochette L, Gambert P, Cottin Y: High plasma N-terminal pro-brain natriuretic peptide level found in diabetic patients after myocardial infarction is associated with an increased risk of in-hospital mortality and cardiogenic shock. Eur Heart J. 2005, 26: 1734-1741. 10.1093\/eurheartj\/ehi260.","journal-title":"Eur Heart J"},{"key":"733_CR19","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1097\/CCM.0b013e31819fe896","volume":"37","author":"R Jarai","year":"2009","unstructured":"Jarai R, Fellner B, Haoula D, Jordanova N, Heinz G, Karth GD, Huber K, Geppert A: Early assessment of outcome in cardiogenic shock: relevance of plasma N-terminal pro-B-type natriuretic peptide and interleukin-6 levels. Crit Care Med. 2009, 37: 1837-1844. 10.1097\/CCM.0b013e31819fe896.","journal-title":"Crit Care Med"},{"key":"733_CR20","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1378\/chest.103.2.565","volume":"103","author":"MR Pinsky","year":"1993","unstructured":"Pinsky MR, Vincent JL, Deviere J, Alegre M, Kahn RJ, Dupont E: Serum cytokine levels in human septic shock: relation to multiple-system organ failure and mortality. Chest. 1993, 103: 565-575. 10.1378\/chest.103.2.565.","journal-title":"Chest"},{"key":"733_CR21","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1093\/eurheartj\/ehi292","volume":"26","author":"P Th\u00e9roux","year":"2005","unstructured":"Th\u00e9roux P, Armstrong PW, Mahaffey KW, Hochman JS, Malloy KJ, Rollins S, Nicolau JC, Lavoie J, Luong TM, Burchenal J, Granger CB: Prognostic significance of blood markers of inflammation in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty and effects of pexelizumab, a C5 inhibitor: a substudy of the COMMA trial. Eur Heart J. 2005, 26: 1964-1970. 10.1093\/eurheartj\/ehi292.","journal-title":"Eur Heart J"},{"key":"733_CR22","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3109\/17482941.2010.523705","volume":"12","author":"A Shpektor","year":"2010","unstructured":"Shpektor A: Cardiogenic shock: the role of inflammation. Acute Card Care. 2010, 12: 115-118. 10.3109\/17482941.2010.523705.","journal-title":"Acute Card Care"},{"key":"733_CR23","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1126\/science.1631560","volume":"257","author":"MS Finkel","year":"1992","unstructured":"Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL: Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science. 1992, 257: 387-389. 10.1126\/science.1631560.","journal-title":"Science"},{"key":"733_CR24","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1253\/circj.CJ-10-0638","volume":"75","author":"CR Sinning","year":"2011","unstructured":"Sinning CR, Sinning JM, Schulz A, Schnabel RB, Lubos E, Wild PS, Papassotiriou J, Bergmann A, Blankenberg S, Munzel T, Bickel C, AtheroGene Study Investigators: Association of serum procalcitonin with cardiovascular prognosis in coronary artery disease. Circ J. 2011, 75: 1184-1191. 10.1253\/circj.CJ-10-0638.","journal-title":"Circ J"},{"key":"733_CR25","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1007\/s00134-003-1827-7","volume":"29","author":"A Geppert","year":"2003","unstructured":"Geppert A, Steiner A, Delle-Karth G, Heinz G, Huber K: Usefulness of procalcitonin for diagnosing complicating sepsis in patients with cardiogenic shock. Intensive Care Med. 2003, 29: 1384-1389. 10.1007\/s00134-003-1827-7.","journal-title":"Intensive Care Med"},{"key":"733_CR26","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s11739-009-0277-9","volume":"4","author":"C Picariello","year":"2009","unstructured":"Picariello C, Lazzeri C, Chiostri M, Gensini G, Valente S: Procalcitonin in patients with acute coronary syndromes and cardiogenic shock submitted to percutaneous coronary intervention. Int Emerg Med. 2009, 4: 403-408. 10.1007\/s11739-009-0277-9.","journal-title":"Int Emerg Med"},{"key":"733_CR27","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0002-8703(99)70241-3","volume":"138","author":"D Hasdai","year":"1999","unstructured":"Hasdai D, Holmes DR, Califf RM, Thompson TD, Hochman JS, Pfisterer M, Topol EJ: Cardiogenic shock complicating acute myocardial infarction: predictors of death. Am Heart J. 1999, 138: 21-31. 10.1016\/S0002-8703(99)70241-3.","journal-title":"Am Heart J"},{"key":"733_CR28","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.jacc.2004.03.060","volume":"44","author":"R Fincke","year":"2004","unstructured":"Fincke R, Hochman JS, Lowe AM, Menon V, Slater JN, Webb JG, LeLemtel TH, Cotter G: Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the SHOCK trial registry: SHOCK Investigators. J Am Coll Cardiol. 2004, 44: 340-348. 10.1016\/j.jacc.2004.03.060.","journal-title":"J Am Coll Cardiol"},{"key":"733_CR29","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0002-9343(01)01070-1","volume":"112","author":"M Koreny","year":"2002","unstructured":"Koreny M, Karth GD, Geppert A, Neunteufl T, Priglinger U, Heinz G, Siostrzonek P: Prognosis of patients who develop acute renal failure during the first 24 hours of cardiogenic shock after myocardial infarction. Am J Med. 2002, 112: 115-119. 10.1016\/S0002-9343(01)01070-1.","journal-title":"Am J Med"},{"key":"733_CR30","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1097\/CCM.0b013e3181b9eb3b","volume":"38","author":"G Marenzi","year":"2010","unstructured":"Marenzi G, Assanelli E, Campodonico J, De Metrio M, Lauri G, Marana I, Moltrasio M, Rubino M, Veglia F, Montorsi P, Bartorelli AL: Acute kidney injury in ST-segment elevation acute myocardial infarction complicated by cardiogenic shock at admission. Crit Care Med. 2010, 38: 438-444. 10.1097\/CCM.0b013e3181b9eb3b.","journal-title":"Crit Care Med"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/cc11467.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/cc11467\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/cc11467.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T12:14:49Z","timestamp":1728303289000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/cc11467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,13]]},"references-count":30,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2012,8]]}},"alternative-id":["733"],"URL":"https:\/\/doi.org\/10.1186\/cc11467","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,13]]},"assertion":[{"value":"21 March 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R152"}}